Phio Pharmaceuticals (PHIO) Operating Margin Growth (3y) (2016 - 2019)
Phio Pharmaceuticals (PHIO) Operating Margin Growth (3y) (2016 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | -2,649.00 |
| 10 | Phio Pharmaceuticals | 13.82 Mn | 13.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 1.22 Mn |
| Mar 31, 2018 | -107,008.00 |
| Dec 31, 2017 | 319,810.00 |
| Jun 30, 2016 | -2.37 Mn |
| Mar 31, 2016 | 470,849.00 |